GlassScriptPhysician profile
John Douglas Dortch
NPI 1114284908
$6,885.70
in general payments reported to CMS, 2019-2025
33 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,334 · 2020: $94.15 · 2021: $63.68 · 2022: $144 · 2023: $519 · 2024: $623 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.64 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,072.85 | 2019-2024 | |
| Medical Device Business Services, INC. | $1,026.89 | 2019 | |
| Kerecis Limited | $417.72 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Endomagnetics LTD | $160.32 | 2023 | Magtrace, Magseed |
| Ethicon US, LLC | $134.52 | 2019-2025 | Vistaseal, Enseal |
| Penumbra, INC. | $133.87 | 2024-2025 | Indigo System |
| Atricure, INC. | $89.02 | 2023-2024 | |
| Kls-Martin L.P. | $81.07 | 2021-2023 | |
| Hologic Sales and Service, LLC | $66.44 | 2023 | Coolseal Generator |
| Endo Pharmaceuticals INC. | $65.88 | 2019-2020 | |
| Organogenesis INC. | $60.08 | 2019 | |
| Csl Behring | $48.39 | 2024 | Kcentra |
| Merck Sharp & Dohme LLC | $44.09 | 2019 | |
| Teleflex LLC | $38.37 | 2023 | Quikclot |
| Edwards Lifesciences Corporation | $37.34 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $35.28 | 2023 | Ti Knot |
| Astrazeneca Pharmaceuticals LP | $33.49 | 2023 | Andexxa |
| Acell, INC. | $32.76 | 2019 | |
| Shire North American Group INC | $27.85 | 2019 | |
| Focal Therapeutics, INC. | $26.41 | 2019 | |
| Smith+Nephew, INC. | $26.25 | 2020 | |
| Cardinal Health 414 LLC | $25.85 | 2019 | |
| Olympus America INC. | $24.45 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.51 | 2025 | |
| Integra Lifesciences Corporation | $21.89 | 2019 | |
| Coloplast Corp | $21.55 | 2025 | |
| Octapharma USA, INC. | $19.73 | 2025 | Fibryga |
| Davol INC. | $19.20 | 2023 | Phasix Mesh |
| Bioventus LLC | $18.70 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Pacira Pharmaceuticals Incorporated | $16.73 | 2022 | |
| Avanos Medical | $14.82 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.56 | 2022 | |
| Reprise Biomedical, INC. | $8.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dortch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.